A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Recommended Citation
Weller M, Berry D, Blondin N, Boulmay B, Buxton M, Chinot O, Colman H, de la Fuente M, de Groot J, Drappatz J, Ducray F, Ellingson B, Galldiks N, Gordon G, Hau P, Hottinger A, Hyddmark V, Khasraw M, Kim L, Lassman A, Lee E, Lim M, Mellinghoff I, Mikkelsen T, Nghiemphu P, Perry J, Ronellenfitsch M, Sulman E, Tabatabai G, Tanner K, Touat M, Wen PY, Wick A. A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro Oncol 2024; 26:1.
Document Type
Conference Proceeding
Publication Date
10-17-2024
Publication Title
Neuro Oncol
Volume
26
First Page
1
